Beijing Balance Medical Technology Co (SHSE:688198) ROCE %

: 9.11% (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beijing Balance Medical Technology Co's annualized ROCE % for the quarter that ended in Sep. 2023 was 9.11%.

Beijing Balance Medical Technology Co ROCE % Historical Data

The historical data trend for Beijing Balance Medical Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Balance Medical Technology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

23.55

14.08

6.07

5.43

10.06

Beijing Balance Medical Technology Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %																10.01	13.86	5.02	11.58	9.11

Beijing Balance Medical Technology Co ROCE % Calculation

Beijing Balance Medical Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	106.216	/	( ( (1030.956 - 36.6)	+	(1179.66 - 63.26) )	/ 2 )
	=	106.216	/	( (994.356	+	1116.4)	/ 2 )
	=	106.216	/	1055.378
	=	10.06 %

Beijing Balance Medical Technology Co's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	107.76	/	( ( (1214.668 - 60.799)	+	(1266.476 - 55.356) )	/ 2 )
	=	107.76	/	( ( 1153.869	+	1211.12 )	/ 2 )
	=	107.76	/	1182.4945
	=	9.11 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Beijing Balance Medical Technology Co (SHSE:688198) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beijing Balance Medical Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Beijing Balance Medical Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Balance Medical Technology Co (SHSE:688198) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Balance Medical Technology Co Ltd (SHSE:688198) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Huachang Road, East District, Science Park, Changping District, Beijing, CHN, 102200

Website

http://www.bairenmedical.com

Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.

Beijing Balance Medical Technology Co (SHSE:688198) Headlines

No Headlines